Product NDC: | 0003-0893 |
Proprietary Name: | ELIQUIS |
Non Proprietary Name: | apixaban |
Active Ingredient(s): | 2.5 mg/1 & nbsp; apixaban |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0003-0893 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202155 |
Marketing Category: | NDA |
Start Marketing Date: | 20121228 |
Package NDC: | 0003-0893-21 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0893-21) |
NDC Code | 0003-0893-21 |
Proprietary Name | ELIQUIS |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0003-0893-21) |
Product NDC | 0003-0893 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | apixaban |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20121228 |
Marketing Category Name | NDA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | APIXABAN |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes |